Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
RX.V / BIOYF and WLDN are getting some love today.
BIOYF / RX.V - An insider purchased 5,000 shares yesterday. I don't know who it is yet.
http://www.tmxmoney.com/TMX/HttpController?GetPage=SearchInsiderTrade&Language=en&Submit=Submit&QuerySymbol=Rx&x=25&y=17
Not that I'm aware of.
I have no position in IVFH.
New Radio Program with Ian Cassel:
http://microcapclub.com/2015/08/microcap-investing-during-market-corrections-and-bear-markets/
New Radio Program with Ian Cassel:
http://microcapclub.com/2015/08/microcap-investing-during-market-corrections-and-bear-markets/
It is in there.
Here is a link to the most recent filing with the Auer Fund info. Search for Auer Growth Fund to look at the correct section.
http://www.sec.gov/Archives/edgar/data/1199046/000119312515141591/d905585dnq.htm
Here is the search I used to find it. You can use it to find older filings for them:
https://searchwww.sec.gov/EDGARFSClient/jsp/EDGAR_MainAccess.jsp?search_text=Auer&sort=Date&formType=FormNQ&isAdv=true&stemming=true&numResults=10&numResults=10
Thanks for the comments. I'll get you the info on the Auer Fund.
SCRH is interesting but I will not touch it. Ethically and religiously I can't invest in a company in the strip club business.
Thanks
Our programmer found it or created it. Why?
New Radio Program with Ian Cassel http://microcapclub.com/2015/08/microcap-investing-during-market-corrections-and-bear-markets/
New Radio Program with Ian Cassel http://microcapclub.com/2015/08/microcap-investing-during-market-corrections-and-bear-markets/
This is just textbook capitulation. I was even predicting it privately with a friend on Friday. When you have tons of selling at the end of the week like we did last weekend, that gives people the weekend to freak out. Many people spent the weekend looking at their brokerage accounts and decided to sell at all cost on Monday. That is the type of thing that gives bottoms.
I have no idea if this is a near term bottom or a long term bottom. I'm not predicting the direction going forward. Having said that, on the right growth names I'm dollar cost averaging my large pile of cash.
Buy 300 shares of BIOYF / RX.V for the SwingTrade Portfolio at US$4.86.
While the day is young, I will not be surprised if we close green.
Today feels like a capitulation day at least for the near term. I suspected that was what today was going to feel like on Friday. By capitulation day I mean a near term bottom as people puke out stock. I purchased some things near the open. Purchases include SPY, RX.V, TIK, & OML.V. The SPY purchase is a very short term purchase which I may not hold at the close.
Shouldn't Buzz be showing up right about now?
I think there is a strong chance that BIOYF / RX.V exceeds $5M in revenue for Q3. They had $1.5M of revenue in July, their large $627,512 international order shipped in August, and it is a big quarter for Insecticide Sales. I'll be happy if they just meet the one analyst expectation for Q3 of $4.6M in revenue and EPS of $0.08. However, I think there is a strong chance they blow that away.
I added shares today to RX.V / BIOYF. It is my largest holding by far and I continue to add. This is one where I am comfortable to hold for the long term (e.g. 3 years). I'm not saying I necessarily will because I always continuously evaluate my positions. However, I think it has the potential to be a stock that I hold that long given their long history of growth.
This is a great blog post: http://microcapclub.com/2014/08/the-conviction-to-hold/
There have been several insider purchases now on PSIX including a large purchase by the CEO.
http://finance.yahoo.com/q/it?s=PSIX+Insider+Transactions
RX.V / BIOYF BioSyent Pharma Acquires Exclusive Rights For Cysview(R) In Canada
http://finance.yahoo.com/news/biosyent-pharma-acquires-exclusive-rights-120000316.html
RX.V / BIOYF BioSyent Pharma Acquires Exclusive Rights For Cysview(R) In Canada
http://finance.yahoo.com/news/biosyent-pharma-acquires-exclusive-rights-120000316.html
Here is my latest blog:
http://microcapclub.com/2015/08/stock-research-in-unusual-places/
Here is my latest blog:
http://microcapclub.com/2015/08/stock-research-in-unusual-places/
The excerpt spoke to the reason for the increase and the likelihood of it repeating. I've seen companies give commentary that indicates that the quarter will repeat for example when they know another order is coming. Obviously, I'm not expecting them to guarantee anything.
Is sharing of research not allowed here anymore?
Don't count on that ASNB quarter repeating. This is what they said in the 10-Q: "Product sales of our biomaterials for the three months ended June 30, 2015 were $1,048,000 as compared with $366,000 for the prior year period, an increase of $682,000, or 186.3%. The increase is due to increased product sales to a significant customer. Although we anticipate continuing purchases from this significant customer, in addition to continuing product sales to other existing and new customers, there can be no assurances that product sales will be consistent with those realized during the three months ended June 30, 2015."
Sell 1500 shares of DAP-U.V / XPLT at $3.9015 for the SwingTrade Portfolio.
This is a tough one to sell. I really like the company and management. The problem is, however, that lots of expectations are built into the price. If they don't produce big growth this quarter, the stock could get really punished. Plus, when you have the backdrop of the market, high PE stocks are not the greatest place to be. I might be very wrong with this sell but I'd rather have the cash now. I'll look to reenter if I get a more favorable risk/reward situation.
I looked at UCLE yesterday but this tidbit from the 10-Q is one thing that caused me to pause: "For the next twelve months, we anticipate we will need approximately $5,000,000 in additional capital to fund our business plans. If we do not raise the required capital we may not meet our expenses and there can be no assurance that we will be able to do so and if we do, we may find the cost of such financing to be burdensome on the Company. Additionally, we may not be able to execute on our business plans due to unforeseen market forces such as lower natural gas prices, difficulty attracting qualified executive staff, general downturn in our sector or by competition as we operate in an extremely competitive market for all of our product offerings."
XPLT / DAP-U.V prints another fresh 52 week high.
SLGD reported pre-tax income of $0.066/share. I'm still reading the report.
Buy 2000 shares of SLGD for the SwingTrade Portfolio at $1.18.
RX.V / BIOYF Biosyent is getting some love.
Good question.
I'm holding PFHO. Management has been very good. I may have to be patient, but I think it has a good chance to do well over the long term. Time will tell.
RX.V / BIOYF is in with another good quarter. There was a timing issue of a large $628K international order that made Q2 a little light but Q3 looks to be stellar. June and July were both $1.5M revenue months. Also, remember that Q3 is seasonally stronger for insecticide sales. I'm expecting the 2015 EPS estimate for the one analyst of $0.28 to be exceeded. The stock is trading up slightly on the report.
http://finance.yahoo.com/news/biosyent-releases-first-six-months-120000033.html
XPLT / DAP-U.V has been moving nicely recently including today. It is up C$0.16 to C$3.65.